Baseline | Follow-up | |||
---|---|---|---|---|
Parameters | With dysphagia | Without dysphagia | With dysphagia | Without dysphagia |
Number of patients | 8 | 15 | ||
Sex (M/W) | 6/ 2 | 4 /11 | ||
Age (years) | ||||
Mean | 67.8±3.11 | 65.2±4.02 | ||
Range | 63–71 | 60–74 | ||
Disease duration (years) | 6.75±3.73* | 3.53±3.58 | ||
MMSE | 28.5±1.93 | 28.5±1.51 | 27.9 ± 2.80 | 28.4 ± 1.60 |
Hoehn-Yahr stage | 2.75±0.27 | 2.37±0.67 | 3.06 ± 0.42 | 2.93 ± 0.53 |
UPDRS motor score | 23.4±7.05* | 14.8±7.49 | 21.0 ± 5.93 | 17.4 ± 11.1 |
L-dopa equivalent dose (mg/day) | 400±311 | 267±321 | 590±155 | 514±311 |
Values are mean±SD or the number of patients.
*Significant difference p<0.05 between with and without dysphagia.
M, men; MMSE, Mini-Mental State Examination; PD, Parkinson's disease; UPDRS, unified Parkinson's disease rating scale; W, women.